-
All the planets appear to be lining up to make a persuasive "business case" for infection control.
-
Hospitalizations related to methicillin-resistant Staphylococcus aureus (MRSA) infections more than doubled, from 127,000 to nearly 280,000, between 1999 and 2005, according to a new study.
-
The Centers for Disease Control and Prevention is responding to a recent Washington Post report that CDC estimates of new HIV infections in Americans annually may be 50% higher than previously believed.
-
Alarmed by continuing deaths and severe adverse reactions after treatment for latent tuberculosis, the Centers for Disease Control and Prevention is seeking funding approval for a national surveillance system to track the events.
-
-
The perception of health care risks motivates behaviors in healthcare workers as well as patients.
-
Lipid abnormalities can be problematic in HIV-positive patients receiving highly active antiretroviral therapy (HAART) due to the risk of premature coronary artery disease developing in susceptible patients.
-
Increasingly, hospitals are being required to make public their surveillance data on hospital-related infections as quality indicators.
-
In this issue: FDA warnings for existing drugs dominate pharmaceutical news this month.
-
